
|Articles|December 1, 2002
CMV retinitis treatment responding to changing HIV therapy
Editor's Note: HIV/AIDS continues to be a major health problem, not only in the developing world, but in North America and Europe as well. Although the incidence of ocular complications of HIV/AIDS has decreased dramatically since the introduction of highly active anti-retroviral therapy (HAART), the prevalence of HIV positivity continues toincrease, particularly among heterosexual women and minorities.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approvals in 2025: What changed and why it matters for ophthalmologists
2
Achieving a new level of refractive precision: Surgical strategies
3
What changed in glaucoma care in 2025: Surgeon perspective
4
Global trial equity: How LMIC data is reshaping US ophthalmology research
5




